The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Torleva     (2S)-2-(2-oxopyrrolidin-1- yl)butanamide

Synonyms: Keppra, Levetiractam, Levetiracetam, Levetriacetam, Leviteracetam, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Levetiracetam

  • LEV (25, 50, and 100 mg/kg, p.o.) had no effects on afterdischarge induction and slightly decreased afterdischarge duration, whereas it markedly decreased seizure stage and motor seizure duration [1].
 

Psychiatry related information on Levetiracetam

 

High impact information on Levetiracetam

  • RESULTS: More than 40% of subjects in clinical trials of tiagabine (TGB), topiramate (TPM), and levetiracetam (LEV) experienced an increase in seizures while taking a placebo [3].
  • GBP, LTG, TGB, and LEV, at low concentrations, do not significantly change the metabolic activities examined and do not demonstrate toxic actions on astrocytes [4].
  • This study reports the solubilization of the rat synaptic vesicle protein SV2A, the brain binding site for the antiepileptic drug levetiracetam (LEV), and its characterization [5].
  • Competition binding experiments with a variety of LEV analogues indicated that [3H]ucb 30889 labels the same binding site in both crude homogenates and soluble extracts, with still high stereoselectivity [5].
 

Gene context of Levetiracetam

  • N-dodecyl-beta-D-maltoside (DDM) was the best detergent at achieving a high percentage of SV2A solubilization and at maintaining the binding characteristics of a tritiated form of a more potent analogue of LEV, [3H]ucb 30889 ((2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide) [5].

References

  1. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. Kitano, Y., Komiyama, C., Makino, M., Kasai, Y., Takasuna, K., Kinoshita, M., Yamazaki, O., Takazawa, A., Yamauchi, T., Sakurada, S. Epilepsia (2005) [Pubmed]
  2. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability. Simister, R.J., Sander, J.W., Koepp, M.J. Epilepsy & behavior : E&B (2007) [Pubmed]
  3. Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials? Somerville, E.R. Neurology (2002) [Pubmed]
  4. An in vitro study of new antiepileptic drugs and astrocytes. Pavone, A., Cardile, V. Epilepsia (2003) [Pubmed]
  5. Solubilization and immunopurification of rat brain synaptic vesicle protein 2A with maintained binding properties. Lambeng, N., Grossmann, M., Chatelain, P., Fuks, B. Neurosci. Lett. (2006) [Pubmed]
 
WikiGenes - Universities